Lentiviral Integration Insertion Site Standards Expansion
Recently, CB-Gene launched a lentiviral polyclonal multi-integration site reference product with an integration frequency of 5% to 2%. It is a mixture of multiple monoclonal integration site products, covering 20 insertion sites, from 20 genes on 11 different chromosomes.
More >>
Understanding HRD and its Role in Cancer Detection: A Guide for Genomic Testing Companies
Homologous Recombination Deficiency (HRD) refers to a condition where a cell's ability to repair DNA double-strand breaks via the homologous recombination repair (HRR) pathway is compromised. This deficiency can lead to genomic instability, a hallmark of many cancer types.
More >>
Optimizing Cancer Genomic Testing with HRD Reference Standards: A Focus on Precision and Quality
In the field of cancer genomics research, ensuring accurate and reproducible results is critical for the development and validation of high-performance assays. As genomic technologies such as Next-Generation Sequencing (NGS) continue to evolve, the demand for reliable and standardized reference materials has grown.
More >> 